Confirmations scientifiques 13

EQ) Dans le contact 731, daté du 3 février 2020 et publié sur ce site le 6 avril 2020, Billy Meier affirme que le coronavirus peut demeurer de manière latente dans l'organisme et se manifester plusieurs années plus tard de manière différente dans des contacts intimes :
17) Nos observations et nos découvertes montrent également que le virus corona génétiquement modifié une deuxième fois se comporte de manière très agressive jusqu'à en être mortel dans l'organisme humain, selon l'état immunitaire concerné, et qu’il faut rester circonspect, lors d’un rétablissement qui ne correspondrait pas à une destruction complète du virus. Nos résultats montrent que certaines variantes génétiques ne meurent pas, même pendant la convalescence, mais restent présentes de manière latente, sans être immédiatement reconnaissables ou détectables, comme c'est le cas pour diverses autres maladies. Dans le cas de cette maladie corona insidieuse, il peut toutefois arriver inopinément quelques années ou décennies plus tard, par exemple lors d'un contact intime, que le mal latent et dormant puisse être transmis, mais alors un phénomène inhabituel se produit de telle manière que, suite aux variations génétiques modifiées du virus connu, une réaction à la maladie se produise sous une forme complètement différente. Cependant, ce fait ne peut être saisi par la recherche terrestre avec des appareils médicaux et virologiques et d'autres technologies car, selon nos prédictions, les instruments nécessaires à cette fin ne peuvent pas encore être développés et construits dans l'actuel troisième millénaire. Bien que les habitants de la terre croient avoir à leur disposition une technologie très développée avec des valeurs techniques très avancées, ce qui est vrai, il convient de souligner que l'ensemble de la technologie terrestre, quelle qu'elle soit, n'est qu'un premier pas pour sortir de l'obscurité profonde vers une faible lueur d'une lumière encore très lointaine.

http://billymeiertraductionsfr.blogspot.com/2020/04/contacts-731-et-734.html

-------------------->

Ceci n'est bien évidemment pas encore prouvé, mais un récent article du guardian daté du 7 mai 2020 pourrait pointer sur cette possibilité :

Covid-19 found in semen of infected men, say Chinese doctors Authors claim study based on small number of patients opens up chance of sexual transmission

Chinese researchers who tested the sperm of men infected with Covid-19 found a minority had the new coronavirus in their semen. According to the researchers, this opened up a small chance the disease could be sexually transmitted, though this claim has been questioned by other academics in the wake of the findings being published.

Such commentators have noted that while viral genome may be found in body secretions, it must be new and active to be infectious. It is unclear from the Chinese study whether the researches found old traces, or active new virus.

...

Sheena Lewis, a professor of reproductive medicine at Queen’s University Belfast, stressed that this was a “very small study” and said its findings were in keeping with other small studies showing low or no Sars-CoV-2 in tests of semen samples. “However, the long-term effects of Sars-CoV-2 on male reproduction are not yet known,” she said.

https://www.theguardian.com/world/2020/may/07/covid-19-found-in-semen-of-infected-men-say-chinese-doctors

La publication elle=même date du 7 mai :

https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2765654



ER) Billy souligne l'intérêt de l'usage de l'interferon utilisé par les Plejaren comme remède pour renforcer le système immunitaire.
Ptaah
363. You are thus addressing a topic on which we have been sending out instructive impulses to the world's leading scientists for some time, which is why I can also give you an official answer to this question.
364. Certainly, the possibility of producing such drugs of a prophylactic and treatable nature is given.
365. The name of such a medicine would first have to be invented by the manufacturers, whereas we simply call it SALUBRITASON, which in German means simply remedy.
366. The name is thus pronounced in such a way that the 'O' is emphasized in a drawn-out manner, as you have just heard from me.
Billy
So SALUBRITASOON – pronounced with two 'Os' so to speak.
Ptaah
367. That's right.
368. But keep listening:
369. The actual active ingredient for a drug, as you mentioned it, in both forms, i.e. for acute treatment and prophylactic application, is already known to medical scientists around the world as GAMMA-INTERFERON.
370. This substance GAMMA-INTERFERON must now only be isolated by the responsible specialists and separated from the corresponding products, which contain this high-quality defence substance against pathogens, in order to then process it into a corresponding medicine, which can be administered to humans.
371. The substance GAMMA-INTERFERON is a natural product of chemical transformation, e.g. when milk is converted to YOGURT or KEFIR.
372. So it is only necessary that the GAMMA-INTERFERON is removed from the mentioned products and converted into a drug.
373. Disease-prone people should take such a medication prophylactically daily in an appropriate amount, in addition to the necessary vitamins, trace elements and minerals, whereby special care should also be taken with vitamin C that a daily requirement of at least 900 milligrams is required per adult human unit if it has a reasonably balanced and health-promoting vitamin C requirement and wants to be healthy.
374. The 75-150 milligrams established in this respect by the earthly physicians unfortunately correspond to extremely erroneous assumptions, whereas your calculations are very realistic, if I compare your data made to me regarding the vitamin C as well as the other vitamins and trace elements and minerals, which you take and also recommend.
Billy
So this GAMMA-INTERFERON is practically the same antidote or anti-substance against pathogens as it is produced by the human immune system itself?
Ptaah
375. Sort of, yes.
Billy
Then it also works in the same way as the natural products in terms of antibodies and defences of the human immune system?
Ptaah
376. This is so.
377. The effect is even better if the drug is taken in larger controlled and appropriate amounts.
378. It is able to prevent almost any disease and to nip it in the bud, even cancer of any kind, because when taken and used in appropriate quantities, it is able to destroy even the most persistent viruses, not to mention less resistant pathogens.
Billy
Then it is only to be hoped that the medical tinkerers and other clever people will soon find the way and the means to produce this remedy and make it available to mankind.
Ptaah
379. This is also our wish, because this medicine alone could contain or prevent many and often painful evils on Earth.
Billy
Should the consumption of yogurt or kefir be the only benefit?
Ptaah
380. That is correct, but larger quantities must be enjoyed, daily.
381. An appropriately dosed medication would be more useful and less cumbersome.
Billy
Do you also use such drugs?
Ptaah
382. In extreme cases yes, but otherwise we don't take it as an actual medicine, but as a preventive, i.e. prophylactically as a daily food supplement.
383. Our coordination of the anti-substance is dosed and adjusted to the individual person in such a way that no more diseases appear.
www.futureofmankind.co.uk/Billy_Meier/Contact_Report_238
Covid-19 emerged in the Chinese city of Wuhan in late December 2019, and by January 2020 it had hit Hubei province like a tidal wave, swirling over China and rippling out overseas.

The Chinese state rolled into action to combat its spread and care for those infected. Amongst the 30 medicines chosen by the Chinese National Health Commission to fight the virus was a Cuban anti-viral drug called Interferon Alfa-2B, which has been produced in China by the Cuban-Chinese joint venture ChangHeber since 2003.

Interferon Alfa-2B and Cuban biotechnology

Cuban Interferon Alfa-2B has proven effective for viruses with characteristics similar to those of Covid-19. Cuban biotech specialist Dr Luis Herrera Martínez explains that “its use prevents aggravation and complications in patients, reaching that stage that can ultimately result in death.”
...
The international history of Cuban interferons

Interferons are “signalling” proteins produced and released by cells in response to infections in order to prompt nearby cells to heighten their anti-viral defences. They were first identified in 1957 by Jean Lindenmann and Aleck Isaacs in London. In the 1960s, Ion Gresser, a US researcher in Paris, showed that interferons stimulate lymphocytes that attack tumours in mice. In the 1970s, US oncologist Randolph Clark Lee took up this research.
Diagram showing how interferons stimulate immune response in other cells
Interferons released by a cell infected with a virus prompt neighbouring cells to help stem the infection (CNX OpenStax, CC BY 4.0)

Catching the tail end of US President Carter’s improved relations with Cuba, Dr Clark Lee visited Cuba, met with Fidel Castro, and convinced him that interferons could become the wonder drug. Shortly afterwards, a Cuban doctor and a haematologist spent time in Dr Clark Lee’s laboratory, returning with the latest research about interferon and more contacts.

In March 1981, six Cubans spent 12 days in Finland with the Finnish doctor Kari Cantell, who in the 1970s had isolated interferon from human cells, and had shared the breakthrough by declining to patent the procedure. The Cubans learned to produce large quantities of interferons.

Within 45 days of returning to the island, they had produced the first Cuban batch of interferon, the quality of which was confirmed by Cantell’s laboratory in Finland. Just in time, it turned out.
Cuba’s 1981 dengue epidemic

Weeks later Cuba was struck by an epidemic of dengue, a disease transmitted by mosquitos. It was the first time this particularly virulent strand, which can trigger life-threatening dengue haemorrhagic fever, had appeared in the Americas.

The epidemic affected 340,000 Cubans, with 11,000 new cases diagnosed every day at its peak. 180 people died, including 101 children. The Cubans suspected the CIA of releasing the virus. The US State Department denied it, but a recent Cuban investigation claims to provide evidence that the epidemic was introduced from the US.

Cuba’s Ministry of Public Health authorised the use of Cuban interferon to halt the dengue outbreak. It was done at great speed, and mortality declined.

In their historical account, Cuban medical scientists Caballero Torres and López Matilla wrote:

    It was the most extensive prevention and therapy event with interferon carried out in the world. Cuba began to hold regular symposia, which quickly drew international attention.



Covid-19 emerged in the Chinese city of Wuhan in late December 2019, and by January 2020 it had hit Hubei province like a tidal wave, swirling over China and rippling out overseas.

The Chinese state rolled into action to combat its spread and care for those infected. Amongst the 30 medicines chosen by the Chinese National Health Commission to fight the virus was a Cuban anti-viral drug called Interferon Alfa-2B, which has been produced in China by the Cuban-Chinese joint venture ChangHeber since 2003.

Interferon Alfa-2B and Cuban biotechnology

Cuban Interferon Alfa-2B has proven effective for viruses with characteristics similar to those of Covid-19. Cuban biotech specialist Dr Luis Herrera Martínez explains that “its use prevents aggravation and complications in patients, reaching that stage that can ultimately result in death.”
...
The international history of Cuban interferons

Interferons are “signalling” proteins produced and released by cells in response to infections in order to prompt nearby cells to heighten their anti-viral defences. They were first identified in 1957 by Jean Lindenmann and Aleck Isaacs in London. In the 1960s, Ion Gresser, a US researcher in Paris, showed that interferons stimulate lymphocytes that attack tumours in mice. In the 1970s, US oncologist Randolph Clark Lee took up this research.
Diagram showing how interferons stimulate immune response in other cells
Interferons released by a cell infected with a virus prompt neighbouring cells to help stem the infection (CNX OpenStax, CC BY 4.0)

Catching the tail end of US President Carter’s improved relations with Cuba, Dr Clark Lee visited Cuba, met with Fidel Castro, and convinced him that interferons could become the wonder drug. Shortly afterwards, a Cuban doctor and a haematologist spent time in Dr Clark Lee’s laboratory, returning with the latest research about interferon and more contacts.

In March 1981, six Cubans spent 12 days in Finland with the Finnish doctor Kari Cantell, who in the 1970s had isolated interferon from human cells, and had shared the breakthrough by declining to patent the procedure. The Cubans learned to produce large quantities of interferons.

Within 45 days of returning to the island, they had produced the first Cuban batch of interferon, the quality of which was confirmed by Cantell’s laboratory in Finland. Just in time, it turned out.
Cuba’s 1981 dengue epidemic

Weeks later Cuba was struck by an epidemic of dengue, a disease transmitted by mosquitos. It was the first time this particularly virulent strand, which can trigger life-threatening dengue haemorrhagic fever, had appeared in the Americas.

The epidemic affected 340,000 Cubans, with 11,000 new cases diagnosed every day at its peak. 180 people died, including 101 children. The Cubans suspected the CIA of releasing the virus. The US State Department denied it, but a recent Cuban investigation claims to provide evidence that the epidemic was introduced from the US.

Cuba’s Ministry of Public Health authorised the use of Cuban interferon to halt the dengue outbreak. It was done at great speed, and mortality declined.

In their historical account, Cuban medical scientists Caballero Torres and López Matilla wrote:

    It was the most extensive prevention and therapy event with interferon carried out in the world. Cuba began to hold regular symposia, which quickly drew international attention.
https://blogs.lse.ac.uk/latamcaribbean/2020/03/18/cuba-and-coronavirus-how-cuban-biotech-came-to-combat-covid-19/